Therapiva Profile
Key Indicators
- Authorised Capital ₹ 110.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 110.00 Cr
as on 16-06-2024
- Company Age 7 Year, 19 Days
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 142.80 Cr
as on 16-06-2024
- Revenue -23.01%
(FY 2021)
- Profit -30.29%
(FY 2021)
- Ebitda -13.36%
(FY 2021)
- Net Worth -260.23%
(FY 2021)
- Total Assets -2.79%
(FY 2021)
About Therapiva
The Corporate was formerly known as Zexan Laxai Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 110.00 Cr and a paid-up capital of Rs 110.00 Cr.
The company has closed loans amounting to ₹142.80 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Bolloju Brahmanandam and Bandoju Srinivas serve as directors at the Company.
- CIN/LLPIN
U73100TG2017PTC120931
- Company No.
120931
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2017
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Secunderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Therapiva?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bolloju Brahmanandam  | Director | 31-Dec-2021 | Current |
| Bandoju Srinivas | Director | 30-Sep-2021 | Current |
Financial Performance and Corporate Structure Insights of Therapiva.
Therapiva Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 23.01% decrease. The company also saw a substantial fall in profitability, with a 30.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 260.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Therapiva?
In 2021, Therapiva had a promoter holding of 76.92% and a public holding of 23.08%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Osr Infra Projects LlpActive 6 years 6 monthsBolloju Brahmanandam and Bandoju Srinivas are mutual person
Osr Infra Private LimitedActive 14 years 2 monthsBolloju Brahmanandam and Bandoju Srinivas are mutual person
Epione Labs Private LimitedActive 12 years 6 monthsBolloju Brahmanandam and Bandoju Srinivas are mutual person
Catalysis Pharma Private LimitedActive 4 years 9 monthsBolloju Brahmanandam and Bandoju Srinivas are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Dec 2018 | ₹142.80 Cr | Satisfied |
How Many Employees Work at Therapiva?
Therapiva has a workforce of 127 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Therapiva, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Therapiva's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
